Edgar Gonzalez-Kozlova

A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma - PubMed These findings suggest the opportunity for patient stratification and the potential for more durable antitumor immune responses in future clinical trials of this multimodal standard of care and combin...

I'm excited to have been part of the correlative study for clinical trial NCT03576612 GMCI, Nivolumab, and Radiation Therapy in Treating Patients with Newly Diagnosed High-Grade Gliomas in a multicenter effort pubmed.ncbi.nlm.nih.gov/40120123/
@sinaiimmuno.bsky.social
@GnjaticLab

Fantastic Webinar series on Current Immuno-Oncology advances and includes outstanding Professors such as Sacha Gnjatic from @sinaiimmuno.bsky.social !

Read about one of recent studies about discovery of new biomarkers to improve treatment and diagnostics of endometrial cancer! @sinaiimmuno.bsky.social
www.mountsinai.org/about/newsro...